Pfizer Announces Ambitious Cost-Cutting Plan to Achieve $1.5 Billion Savings by 2027
Wednesday, 22 May 2024, 19:13
Pfizer’s Strategic Cost Reduction Plan
Pfizer is aiming to save $1.5 billion by 2027 through a new cost-cutting initiative. The pharmaceutical giant is also proceeding with a $4 billion cost-cutting endeavor announced earlier, driven by weakened demand for its Covid vaccine and drug Paxlovid.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.